Boothbay Fund Management, LLC Sage Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $5.01 Million - $8.48 Million	473,500 New	473,500 $5.14 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $942,797 - $1.4 Million	30,700 New	30,700 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.16 Million - $1.65 Million	-28,700 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $1.58 Million - $2.28 Million	28,700 New	28,700 $1.63 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.